Softcare Limited (HKG:2698)

Softcare Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Revenue	567.39	454.39	411.37	319.9
Revenue Growth (YoY)	24.87%	10.46%	28.59%	-
Cost of Revenue	363.88	294.24	267.62	246.37
Gross Profit	203.5	160.15	143.75	73.53
Selling, General & Admin	59.1	44.14	49.15	37.84
Research & Development	1.18	0.53	0.34	0.16
Operating Expenses	60.27	44.67	49.49	37.99
Operating Income	143.23	115.48	94.25	35.54
Interest Expense	-1.42	-0.46	-1.39	-6.98
Interest & Investment Income	1.93	0.39	0.39	0.05
Currency Exchange Gain (Loss)	5.4	-0.12	-13.75	-4.36
Other Non Operating Income (Expenses)	-4.71	-2.92	0.05	0.36
EBT Excluding Unusual Items	144.43	112.37	79.55	24.6
Gain (Loss) on Sale of Investments	0.15	0.67	0.25	0.03
Gain (Loss) on Sale of Assets	0.1	0.05	-3.32	-0.01
Pretax Income	144.67	113.08	76.49	24.62
Income Tax Expense	23.51	17.97	11.81	6.23
Net Income	121.16	95.11	64.68	18.39
Net Income to Common	121.16	95.11	64.68	18.39
Net Income Growth	27.39%	47.05%	251.71%	-
Shares Outstanding (Basic)	527	500	500	500
Shares Outstanding (Diluted)	528	500	500	500
Shares Change (YoY)	5.59%	-	-	-
EPS (Basic)	0.23	0.19	0.13	0.04
EPS (Diluted)	0.23	0.19	0.13	0.04
EPS Growth	20.91%	47.05%	251.71%	-
Free Cash Flow	-	82.99	90.16	-17.79
Free Cash Flow Per Share	-	0.17	0.18	-0.04
Dividend Per Share	0.089	-	-	-
Gross Margin	35.87%	35.24%	34.94%	22.99%
Operating Margin	25.24%	25.41%	22.91%	11.11%
Profit Margin	21.36%	20.93%	15.72%	5.75%
Free Cash Flow Margin	-	18.26%	21.92%	-5.56%
EBITDA	150.97	123.22	101.89	42.38
EBITDA Margin	26.61%	27.12%	24.77%	13.25%
D&A For EBITDA	7.74	7.74	7.64	6.84
EBIT	143.23	115.48	94.25	35.54
EBIT Margin	25.24%	25.41%	22.91%	11.11%
Effective Tax Rate	16.25%	15.89%	15.44%	25.31%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.